Interaction-mediating sequences within class I viral fusion glycoproteins : their roles in viral infection and in applications

Abstract

Class I viral fusion glycoproteins facilitate fusion of the viral envelope with cell membranes and entry of the virus into the cell, through extensive short sequence-specific interactions. Regions mediating these interactions include the N-terminal hydrophobic fusion peptide, a pair of extended 4,3-hydrophobic heptad repeats (HRs), a membrane-active membrane proximal external region (MPER), a hydrophobic transmembrane domain and the cytoplasmic tail region. In particular, the anti-parallel binding of the C-terminal HR to the central N-HR trimeric coiled-coil forms the 6-helix bundle fusion core. These interaction-mediating sequences are generally well preserved sequentially and structurally, allowing their peptidyl analogues to be developed as antiviral therapeutics and/or research reagents (e.g. HR-derived peptides). Novel targets for the development of antiviral drugs and viral detection reagents are required when facing drug-resistant viral strains, viral pathogens without effective and/or economical treatment, and newly emerging viral pathogens. This thesis focuses on the systematic identification of novel interaction-mediating sequences within Class I viral fusion glycoproteins, and the investigation of their involvements in viral replication as well as their potential applications in diagnosis and anti-viral interventions.

In Paper I, peptide array scanning identified 34 spike (S) protein-derived peptides that bound to the S protein of severe acute respiratory syndrome-associated coronavirus (SARS-CoV). These putative self-binding peptides contain five core octapeptide consensus sequences, among which the octapeptide GINITNFR was predicted to form β-zipper-mediated amyloid-like fibrils. The peptide C6 containing this sequence was subsequently shown to oligomerize and form amyloid-like fibrils. The potential of C6 to conduct β-zipper-mediated interactions was further applied to detect the S protein expression by immunofluorescence staining. The peptide array scanning in Paper I used the S protein ectodomain without the MPER and beyond. Using chemical crosslinking and immunofluorescence staining, in Paper II we could show that the S protein MPER could oligomerize and further heteromerize with the N-terminal internal fusion peptide (IFP). The MPER-derived peptides also inhibited the coronavirus entry in a dose-dependent manner, potentially through disrupting the MPER-mediated interactions.

The ability of peptides derived from the MPER in inhibiting viral entry and infection was subsequently studied in Paper III, in the context of HIV-1. The antiviral activities of the HIV-1 Env MPER-derived peptides were abrogated upon Ala substitution of the Trp residues or deletion of the C-terminal cholesterol-interacting motif. Unexpectedly, Ala substitutions of the Trp residues within HIV-1 Env significantly elevated the biosynthesis of another viral structural protein, the p55/Gag, which led to enhanced viral particle release. In Paper IV, besides the MPER we identified the signal sequence of HIV-1 Env as another region that could negatively regulate the expression of p55/Gag. The HIV-1 Env signal sequence, which mediates the co-translational translocalization of nascent Env polypeptide into the endoplasmic reticulum, inhibited the viral protein expression and production, probably at a post-ER-targeting stage. N-terminal truncations of the Env signal sequence significantly elevated the intracellular and intraviral levels of late viral proteins and the proviral genome transcription in a time- and dose-dependent fashion. Moreover, the truncations suppressed the HIV-1 promotor (LTR)-driven expression of a reporter protein, suggesting that the Env signal sequence inhibited viral genome transcription through LTR-dependent interactions.

This thesis focused on three novel interaction-mediating sequences within two Class I viral fusion glycoproteins, which could regulate the viral infectivity, at both viral entry and assembly, through protein-protein, protein-lipid, and/or protein-nucleic acids interactions. These sequences and the interactions that they are meditating could be further targeted by their peptidyl analogues for viral detection and/or inhibition.